These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6471936)

  • 1. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL; Westermarck T
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selenium and vitamin E in patients with progressive muscular dystrophy].
    Voirin J; Deschrevel G; Guincestre JY; Foucault P; Bureau F; Duhamel JF
    Ann Pediatr (Paris); 1990 Jun; 37(6):377-9. PubMed ID: 2400191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.
    Bäckman E; Nylander E; Johansson I; Henriksson KG; Tagesson C
    Acta Neurol Scand; 1988 Nov; 78(5):429-35. PubMed ID: 3218450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of selenium and vitamin E in boys with muscular dystrophy.
    Gamstorp I; Gustavson KH; Hellström O; Nordgren B
    J Child Neurol; 1986 Jul; 1(3):211-4. PubMed ID: 3298399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
    Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
    Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of systolic intervals in Duchenne progressive muscular dystrophy].
    Wu SC; Secchi MB; Obbiassi M; Fossa L; Radice M; Folli G
    Boll Soc Ital Cardiol; 1981; 26(2):109-15. PubMed ID: 7337766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 9. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phonomechanographic systolic variables in the left ventricle in progressive muscular dystrophy (Duchenne form)].
    Del Nero Junior E; Silva ML; Blanchard NC; Savioli RM; Berretto AC; Lima EV; Ferreira ML; Levy JA
    Arq Bras Cardiol; 1980 Jul; 35(1):19-24. PubMed ID: 7224886
    [No Abstract]   [Full Text] [Related]  

  • 11. Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Tierney RC; Rao PS; Pitner SE; George SL; Givins DR
    Pediatrics; 1982 Dec; 70(6):958-64. PubMed ID: 7145553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with vitamin E and selenite in experimental nutritional muscular dystrophy of pigs.
    ORSTADIUS K; NORDSTROM G; LANNEK N
    Cornell Vet; 1963 Jan; 53():60-71. PubMed ID: 13940417
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the enzymatic differential diagnosis of the involvement of various organs in Erb's progressive muscular dystrophy during three medications].
    Kleine TO; Chlond H
    Enzymol Biol Clin (Basel); 1969; 10(1):39-67. PubMed ID: 5305371
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new supportive therapy of certain progressive muscular dystrophies].
    Schmitt J
    Cah Med; 1972 Oct; 13(13):969-76. PubMed ID: 4642894
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of sodium selenite and alpha-tocopherol on the microcirculation in massive blood loss in dogs].
    Shvetsov IM; Kudrin AN; Rodina LG; Krutik IG; Chulkova IP
    Farmakol Toksikol; 1980; 43(2):177-80. PubMed ID: 7002596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial and ineffective levels of selenium for growth and muscular dystrophy.
    Desai ID
    Br J Nutr; 1968 Dec; 22(4):645-50. PubMed ID: 5715638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
    Buscaino GA; Caruso G
    Acta Neurol (Napoli); 1966; 21(1):33-45. PubMed ID: 4385733
    [No Abstract]   [Full Text] [Related]  

  • 19. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage.
    Edwards RH; Jones DA; Jackson MJ
    Med Biol; 1984; 62(2):143-7. PubMed ID: 6471933
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of congenital myotonia with sodium selenite and vitamin E.
    Bäckman E; Henriksson KG
    J Intern Med; 1992 Oct; 232(4):376-7. PubMed ID: 1328462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.